Showing 1351-1360 of 1732 results for "".
Findings on the Path to a Brain Map
https://practicalneurology.com/diseases-diagnoses/imaging-testing/findings-on-the-path-to-a-brain-map/30732/New research in AD, Parkinson's, and mood disorders.Editor's Message: Should Expensive Therapies Be Avoided?
https://practicalneurology.com/columns/practice-management/editors-message-should-expensive-therapies-be-avoided/30792/- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/30976/Combination Therapy in Alzheimer’s Disease: Long-Term Safety and EfficacyRecent advancements in Alzheimer's disease (AD) treatment highlight the potential benefits of combination therapy using cholinesterase inhibitors (CIs) and memantine (MEM). A pivotal study conducted by Dr. Alireza Atri and coll
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31156/Optimizing Alzheimer’s Disease Management: When and How to Integrate Memantine with Cholinesterase InhibitorsIn the evolving landscape of Alzheimer’s disease (AD) treatment, combining memantine with cholinesterase inhibitors has emerged as a pivotal strategy for managing moderate to severe stages of
- Keeping Tysabri Therapy on Targethttps://practicalneurology.com/columns/practice-management/keeping-tysabri-therapy-on-target/31170/Natalizumab (Tysabri) in Multiple Sclerosis: Balancing Efficacy and SafetyOne year following its reintroduction to the market, natalizumab (Tysabri) continues to be a focal point for multiple sclerosis (MS) specialists striving to optimize its use while mitigating associated risks. Originally withdr
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0307PainMngmt-pdf/31207/Exploring Botulinum Toxin Therapy for Neuropathic Pain ManagementNeuropathic pain, characterized by pain resulting from peripheral or central nervous system injury or dysfunction, includes conditions such as painful diabetic polyneuropathy, post-herpetic neuralgia (PHN), complex regional pain syndro
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31273/Recent advancements and studies in neurology offer promising insights for clinical practice. A GlaxoSmithKline-sponsored trial compared the efficacy of lamotrigine versus topiramate in 192 epilepsy patients. Results demonstrated that lamotrigine outperformed topiramate on cognitive assessments such
- The Tug-of-War Over Medical Liability Reformhttps://practicalneurology.com/columns/practice-management/the-tug-of-war-over-medical-liability-reform/31279/The ongoing struggle over medical liability reform in the United States remains a critical issue for healthcare professionals, particularly within the field of neurology. Physicians across various specialties face increasing malpractice insurance premiums and the pressures of defensive medicine, dri
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31300/Effective budgeting is a cornerstone of successful medical practices, including those in neurology, as highlighted by Craig T. Williams in the June 2006 issue of Practical Neurology. Williams emphasizes that creating, managing, and adhering to a realistic budget is essential for mitigating risks suc
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0506dementia-pdf/31311/In the May 2006 issue of *Practical Neurology*, Dr. David S. Geldmacher explores the enduring impact of the iconic TV character Dr. Marcus Welby on modern medical practice, particularly in the realm of dementia care. Dr. Welby symbolized the epitome of physician excellence—competent, compassionate,